OrbiMed’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.8M Buy
+1,348,825
New +$35.6M 0.45% 49

Other funds holding SCTX

OrbiMed's SCTX Position: Q3 2026 in Review

OrbiMed opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 1,348,825 shares worth $24.8M. The stake represents 0.45% of the portfolio and ranks #49 among its holdings.

62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • OrbiMed held 1,348,825 shares of Scribe Therapeutics worth $24.8M as of Q3 2026.
  • Scribe Therapeutics was a new OrbiMed position in Q3 2026.
  • Scribe Therapeutics made up 0.45% of OrbiMed's portfolio in Q3 2026, its #49 holding.
  • 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.